The Net Margin of Lyell Immunopharma Inc (LYEL) is -562285.25%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -562285.25% |
| 2023-12-31 | -180486.16% |
| 2022-12-31 | -216.25% |
| 2021-12-31 | -2349.48% |
| 2020-12-31 | -2634.92% |
| 2019-12-31 | -19603.03% |